Karyopharm Therapeutics Inc. - Common Stock (KPTI)

1.9950
+0.0750 (3.91%)
NASDAQ· Last Trade: Aug 3rd, 3:50 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Registration Momentum Builds Across the Oncology Pipeline
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · February 17, 2026